The advertisement promotes KEYTRUDA, a prescription medicine for treating early-stage non–small cell lung cancer (NSCLC) that can be surgically removed, highlighting its use in combination with chemotherapy and its role in preventing cancer recurrence.
Creative Information
| CID: | f3447604-ebe9-403d-9688-88d106113e3f |
| CRID: | 2_206_449832 |
| Domain: | keytruda.com |
| Seat: | BSW |
| Size: | 300x250 |
| Bid: | $0.50 |
| Timestamp: | 10/23/2025, 2:13:18 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 5:28:56 PM | 6.38s | |
| adomain_analysis | success | 11/7/2025, 5:28:37 PM | 4.22s | |
| adomain_capture | success | 11/7/2025, 5:28:32 PM | 0.36s | |
| ad_render | success | 11/7/2025, 5:28:49 PM | 16.82s | |
| brand_mapping | success | 11/7/2025, 2:47:22 PM | 0.10s | |
Analysis Results
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1610.04 KB | ||||||||||||||||||||||
| Render Time: | 8.07 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1629.22 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<ins class='dcmads' style='display:inline-block;width:300px;height:250px' data-dcm-placement='N464015.3848558MATTERKIND/B32794367.408693604' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='e5d19742-b410-11f0-8d54-12335f3113c3' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D449832%3BsId%3D719302%3BlId%3D91427%3BcId%3D17823%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3De5d19742-b410-11f0-8d54-12335f3113c3%3BadThdId%3D3399db3d36edcd535ccdd1e3bbce9db2%3BengineId%3Di-0f912a154758c7350%3BdIp%3DNzUuMTM4LjI1MC4yOQ%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D147376%3BinventoryId%3D259726%3BrtdmIndicator%3D1%3Btimestamp%3D1761664511%3Blat%3DMzUuMDc%3Blong%3DLTg4LjYy%3Bdma%3DNjQw%3BstateCode%3D%3Bzip%3DMzgzNjc%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=e5d19742-b410-11f0-8d54-12335f3113c3;lId=91427;sId=719302;cId=17823;crId=449832;adThdId=3399db3d36edcd535ccdd1e3bbce9db2;adExchange=BidSwitch;engineId=i-0f912a154758c7350;dealId=0;geoId=147376;inventoryId=259726;rtdmIndicator=1;timestamp=1761664511;property=merriam-webster.com;dIp=NzUuMTM4LjI1MC4yOQ;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=0;hhId=0;cuid=cuid_4ce49f80-e7d0-11ef-b762-12707100b72d' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_4ce49f80-e7d0-11ef-b762-12707100b72d");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><span id="te-clearads-js-adtheorent01cont449832"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=17823&c=adtheorent01cont449832&w=300&h=250&js=pmw0&plc=tr&uid=3399db3d36edcd535ccdd1e3bbce9db2"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
